MamathaPasnoorMD
Neurology • Kansas City, KSNeuromuscular Medicine, Neurophysiology
Professor, Neurology, UNIVERSITY OF KANSAS MEDICAL CENTER
Dr. Pasnoor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Landon Center on Aging
3599 Rainbow BLVD Mail Stop 2012
Kansas City, KS 66160Phone+1 913-588-6970Fax+1 913-588-6965
Summary
- Dr. Mamatha Pasnoor is a neurologist in Kansas City, KS and is affiliated with The University of Kansas Hospital. She received her medical degree from Osmania Medical College NTR UHS and has been in practice 21 years. She specializes in neuromuscular medicine and neurophysiology and is experienced in general neurology, neuromuscular medicine, and clinical neurophysiology.
Education & Training
University of Kansas School of MedicineFellowship, Clinical Neurophysiology, 2005 - 2006- University of Kansas School of MedicineResidency, Neurology, 2002 - 2005
Grand Rapids Medical Education and Research Center/ Michigan State University (St Mary's)Internship, Transitional Year, 2001 - 2002
Osmania Medical College NTR UHSClass of 1996
Certifications & Licensure
KS State Medical License 2005 - 2025
MO State Medical License 2022 - 2025
MI State Medical License 2001 - 2002- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 212 citationsThe Effect of Exercise on Neuropathic Symptoms, Nerve Function, and Cutaneous Innervation in People with Diabetic Peripheral NeuropathyPatricia M. Kluding, Mamatha Pasnoor, Rupali Singh, Stephen Jernigan, Kevin L. Farmer
Journal of Diabetes and Its Complications. 2012-09-01 - 175 citationsSafety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric
The Lancet. Neurology. 2021-07-01 - 63 citationsSafety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.Jordi Diaz-Manera, Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar
The Lancet. Neurology. 2021-12-01
Journal Articles
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)Richard J Barohn, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, JAMA Neurology
Authored Content
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
Press Mentions
Takeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)January 30th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
